Prognostic value of the Kyoto Prognostic Index in higher-risk diffuse large B-cell lymphomas treated by upfront autologous stem cell transplantation in JCOG0908 trial.

Tsutomu Kobayashi Kazuhito YamamotoYoshitoyo KagamiRyunosuke MachidaKana MiyazakiShigeo NakamuraJunya Kuroda Dai MaruyamaHirokazu Nagai

Published in: Japanese journal of clinical oncology (2022)

The KPI may be a suitable predictor of outcome than the IPI for patients with higher-risk DLBCL treated with upfront intensive immunochemotherapy including ASCT.

Keyphrases

stem cell transplantation
high dose
diffuse large b cell lymphoma
phase iii
clinical trial
study protocol
bone marrow
randomized controlled trial
low grade
low dose
mesenchymal stem cells
platelet rich plasma